Supportive Care in Cancer

, Volume 27, Issue 9, pp 3449–3461 | Cite as

Feasibility of an exercise and nutritional intervention for weight management during adjuvant treatment for localized breast cancer: the PASAPAS randomized controlled trial

  • Aude-Marie Foucaut
  • Magali Morelle
  • Anne-Sophie Kempf-Lépine
  • Cédric Baudinet
  • Renaud Meyrand
  • Séverine Guillemaut
  • Séverine Metzger
  • Valérie Bourne-Branchu
  • Elodie Grinand
  • Sylvie Chabaud
  • David Pérol
  • Julien Carretier
  • Sophie E. Berthouze
  • Eric Reynes
  • Lionel Perrier
  • Paul Rebattu
  • Pierre-Etienne Heudel
  • Thomas Bachelot
  • Patrick Bachmann
  • Béatrice Fervers
  • Olivier Trédan
  • Marina TouillaudEmail author
Original Article



Lack of physical activity (PA), weight gain, and overweight have been associated with increased risk of recurrence and mortality after breast cancer diagnosis. We evaluated the feasibility of implementing an individualized exercise program and nutritional counseling during adjuvant treatment of localized invasive breast cancer.


Sixty-one patients eligible for adjuvant chemotherapy were randomized 2:1 to receive a 6-month program of weekly aerobic exercises associated with nutritional counseling (n = 41) or usual care with nutritional counseling (n = 20, one withdrawal). The primary endpoints were the proportion of patients compliant with two weekly supervised sessions and their overall adherence (i.e., proportion of supervised and unsupervised sessions completed versus planned sessions).


Ten percent of patients in the intervention group were compliant with the two weekly supervised sessions for 6 months, but the overall median adherence rate was 85% of supervised and non-supervised sessions completed. Non-adherence was mainly due to intrinsic reasons (medical, organizational, psychological barriers). Adherence was positively associated with education and baseline PA level and inversely associated with baseline weight and tumor grade. No statistically significant benefits were observed in the intervention group, even if overall PA level and body composition improved and anthropometrics were maintained over time (p < 0.05).


Overall, there was good adherence with the 6-month exercise program during adjuvant treatment for breast cancer, despite poor compliance to twice-weekly supervised sessions. This study highlights the need for flexible exercise modalities and innovative experimental design to reach patients who would most adhere and benefit from intervention.

Trial registration: Identifier: NCT01331772. Registered 8 April 2011,


Breast cancer Physical activity Exercise Clinical trial Nutrition Obesity 



percentage of body fat


adapted physical activity


breast cancer


body mass index


confidence interval


daily energy expenditure


fat free mass


high-density lipoprotein


low-density lipoprotein


metabolic equivalent of task


physical activity


odds ratio





The authors thank all the study participants for their valuable voluntary contribution. The authors thank Dr. Jean-Paul Guastalla (Center Léon Bérard, Lyon, France) for his collaboration in recruiting patients in the study. The authors also thank Margaret Haugh (MediCom Consult, Villeurbanne, France) for language editing and editorial support.

Authors’ contributions

AMF, ASKL, CB, RM, SG, VBB, DP, SB, ER, LP, PB, BF, OT, and MT contributed to conception and design of the trial. PB, BF, and OT were principal investigators. PR, PEH, TB, and OT were investigators. AMF, ASKL, CB, RM, SG, SM, VBB, EG, JC, SB, ER, PB, BF, OT, and MT acquired the data. MM and SC analyzed the data. AMF, MM, SB, PB, BF, OT, and MT participated in the interpretation of the findings. AMF, MM, BF, and MT drafted the manuscript. All of the authors read and approved the final manuscript.


This PASAPAS trial was supported by the Institut National du Cancer (2010-228/VO-HO), Ligue Contre le Cancer (PME 2010-2011), Fondation de France (2010-15024), Cancéropôle Lyon Auvergne Rhône-Alpes (CLARA Programme structurant 2010), and Association Nationale de la Recherche et de la Technologie (CIFRE/ANRT no. 426/2010).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

The study was approved by the French Sud-Est IV ethics committee (Comité de Protection des Personnes), the National Security Agency of Medicines and Health Products that applies for biomedical studies (Agence Nationale de Sécurité du Médicament et des produits de santé), and the French National Committee on Informatics and Privacy (Commission Nationale de l’Informatique et des Libertés).

Informed consent

Informed consent was obtained from all individual participants included in the study.


  1. 1.
    Playdon MC, Bracken MB, Sanft TB, Ligibel JA, Harrigan M, Irwin ML (2015) Weight gain after breast cancer diagnosis and all-cause mortality: systematic review and meta-analysis. J Natl Cancer Inst 107:djv275CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Azrad M, Demark-Wahnefried W (2014) The association between adiposity and breast cancer recurrence and survival: a review of the recent literature. Curr Nutr Rep 3:9–15CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Trédan O, Bajard A, Meunier A, Roux P, Fiorletta I, Gargi T, Bachelot T, Guastalla JP, Lallemand Y, Faure C, Pérol D, Bachmann P (2010) Body weight change in women receiving adjuvant chemotherapy for breast cancer: a French prospective study. Clin Nutr 29:187–191CrossRefPubMedGoogle Scholar
  4. 4.
    Rock CL, Doyle C, Demark-Wahnefried W, Meyerhardt J, Courneya KS, Schwartz AL et al (2012) Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin 62:243–274CrossRefPubMedGoogle Scholar
  5. 5.
    Devoogdt N, Van Kampen M, Geraerts I, Coremans T, Fieuws S, Lefevre J et al (2010) Physical activity levels after treatment for breast cancer: one-year follow-up. Breast Cancer Res Treat 123:417–425CrossRefPubMedGoogle Scholar
  6. 6.
    Milne HM, Wallman KE, Gordon S, Courneya KS (2008) Effects of a combined aerobic and resistance exercise program in breast cancer survivors: a randomized controlled trial. Breast Cancer Res Treat 108:279–288CrossRefPubMedGoogle Scholar
  7. 7.
    Irwin ML, Crumley D, McTiernan A, Bernstein L, Baumgartner R, Gilliland FD, Kriska A, Ballard-Barbash R (2003) Physical activity levels before and after a diagnosis of breast carcinoma: the health, eating, activity, and lifestyle (HEAL) study. Cancer 97:1746–1757CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Coughlin SS, Smith SA (2015) The insulin-like growth factor axis, adipokines, physical activity, and obesity in relation to breast cancer incidence and recurrence. Cancer Clin Oncol 4:24–31PubMedPubMedCentralGoogle Scholar
  9. 9.
    Cramp F, Byron-Daniel J (2012) Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev 11:CD006145Google Scholar
  10. 10.
    Mishra SI, Scherer RW, Snyder C, Geigle PM, Berlanstein DR, Topaloglu O (2012) Exercise interventions on health-related quality of life for people with cancer during active treatment. Cochrane Database Syst Rev 8:CD008465. CrossRefGoogle Scholar
  11. 11.
    Schwartz AL (2000) Exercise and weight gain in breast cancer patients receiving chemotherapy. Cancer Pract 8:231–237CrossRefPubMedGoogle Scholar
  12. 12.
    DeNysschen CA, Brown JK, Cho MH, Dodd MJ (2011) Nutritional symptom and body composition outcomes of aerobic exercise in women with breast cancer. Clin Nurs Res 20:29–46CrossRefPubMedGoogle Scholar
  13. 13.
    Courneya KS, Segal RJ, McKenzie DC, Dong H, Gelmon K, Friedenreich CM et al (2014) Effects of exercise during adjuvant chemotherapy on breast cancer outcomes. Med Sci Sports Exerc 46:1744–1751CrossRefGoogle Scholar
  14. 14.
    Mason C, Alfano CM, Smith AW, Wang C-Y, Neuhouser ML, Duggan C, Bernstein L, Baumgartner KB, Baumgartner RN, Ballard-Barbash R, McTiernan A (2013) Long-term physical activity trends in breast cancer survivors. Cancer Epidemiol Biomark Prev 22:1153–1161CrossRefGoogle Scholar
  15. 15.
    Schmitz KH, Speck RM, Rye SA, DiSipio T, Hayes SC (2012) Prevalence of breast cancer treatment sequelae over 6 years of follow-up: the pulling through study. Cancer 118(Suppl 8):2217–2225CrossRefPubMedGoogle Scholar
  16. 16.
    Phillips M, Flemming N, Tsintzas K (2009) An exploratory study of physical activity and perceived barriers to exercise in ambulant people with neuromuscular disease compared with unaffected controls. Clin Rehabil 23:746–755CrossRefPubMedGoogle Scholar
  17. 17.
    Schmidt ME, Wiskemann J, Armbrust P, Schneeweiss A, Ulrich CM, Steindorf K (2015) Effects of resistance exercise on fatigue and quality of life in breast cancer patients undergoing adjuvant chemotherapy: a randomized controlled trial. Int J Cancer 137:471–480CrossRefPubMedGoogle Scholar
  18. 18.
    Travier N, Velthuis MJ, Steins Bisschop CN, van den Buijs B, Monninkhof EM, Backx F, Los M, Erdkamp F, Bloemendal HJ, Rodenhuis C, de Roos MAJ, Verhaar M, ten Bokkel Huinink D, van der Wall E, Peeters PHM, May AM (2015) Effects of an 18-week exercise programme started early during breast cancer treatment: a randomised controlled trial. BMC Med 13:121CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Touillaud M, Foucaut A-M, Berthouze SE, Reynes E, Kempf-Lépine A-S, Carretier J, Pérol D, Guillemaut S, Chabaud S, Bourne-Branchu V, Perrier L, Trédan O, Fervers B, Bachmann P (2013) Design of a randomised controlled trial of adapted physical activity during adjuvant treatment for localised breast cancer: the PASAPAS feasibility study. BMJ Open 3:e003855CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Loose BD, Christiansen AM, Smolczyk JE, Roberts KL, Budziszewska A, Hollatz CG, Norman JF (2012) Consistency of the counting talk test for exercise prescription. J Strength Cond Res 26:1701–1707CrossRefPubMedGoogle Scholar
  21. 21.
    Kim C-J, Kang D-H, Park J-W (2009) A meta-analysis of aerobic exercise interventions for women with breast cancer. West J Nurs Res 31:437–461CrossRefPubMedGoogle Scholar
  22. 22.
    Byar KL, Berger AM, Bakken SL, Cetak MA (2006) Impact of adjuvant breast cancer chemotherapy on fatigue, other symptoms, and quality of life. Oncol Nurs Forum 33:E18–E26CrossRefPubMedGoogle Scholar
  23. 23.
    Sasso JP, Eves ND, Christensen JF, Koelwyn GJ, Scott J, Jones LW (2015) A framework for prescription in exercise-oncology research. J Cachexia Sarcopenia Muscle 6:115–124CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Berthouze SE, Minaire PM, Castells J, Busso T, Vico L, Lacour JR (1995) Relationship between mean habitual daily energy expenditure and maximal oxygen uptake. Med Sci Sports Exerc 27:1170–1179CrossRefPubMedGoogle Scholar
  25. 25.
    Foucaut A-M, Berthouze SE, Touillaud M, Morelle M, Bourne-Branchu V, Kempf-Lépine A-S, Carretier J, Pérol D, Trédan O, Bachmann P, Fervers B (2015) Deterioration of physical activity level and metabolic risk factors after early-stage breast cancer diagnosis. Cancer Nurs 38:E1–E9CrossRefPubMedGoogle Scholar
  26. 26.
    Kyle UG, Genton L, Hans D, Karsegard L, Slosman DO, Pichard C (2001) Age-related differences in fat-free mass, skeletal muscle, body cell mass and fat mass between 18 and 94 years. Eur J Clin Nutr 55:663–672CrossRefPubMedGoogle Scholar
  27. 27.
    van Waart H, Stuiver MM, van Harten WH, Geleijn E, Kieffer JM, Buffart LM, de Maaker-Berkhof M, Boven E, Schrama J, Geenen MM, Meerum Terwogt JM, van Bochove A, Lustig V, van den Heiligenberg SM, Smorenburg CH, Hellendoorn-van Vreeswijk JAJH, Sonke GS, Aaronson NK (2015) Effect of low-intensity physical activity and moderate- to high-intensity physical exercise during adjuvant chemotherapy on physical fitness, fatigue, and chemotherapy completion rates: results of the PACES randomized clinical trial. J Clin Oncol 33:1918–1927CrossRefPubMedGoogle Scholar
  28. 28.
    Furmaniak AC, Menig M, Markes MH (2016) Exercise for women receiving adjuvant therapy for breast cancer. Cochrane Database Syst Rev 9:CD005001PubMedGoogle Scholar
  29. 29.
    Carayol M, Delpierre C, Bernard P, Ninot G (2015) Population-, intervention- and methodology-related characteristics of clinical trials impact exercise efficacy during adjuvant therapy for breast cancer: a meta-regression analysis. Psychooncology 24:737–747CrossRefPubMedGoogle Scholar
  30. 30.
    Backman M, Wengström Y, Johansson B, Sköldengen I, Börjesson S, Tärnbro S, Berglund Å (2014) A randomized pilot study with daily walking during adjuvant chemotherapy for patients with breast and colorectal cancer. Acta Oncol 53:510–520CrossRefPubMedGoogle Scholar
  31. 31.
    Husebø AML, Karlsen B, Allan H, Søreide JA, Bru E (2015) Factors perceived to influence exercise adherence in women with breast cancer participating in an exercise programme during adjuvant chemotherapy: a focus group study. J Clin Nurs 24:500–510CrossRefPubMedGoogle Scholar
  32. 32.
    Courneya KS, Segal RJ, Gelmon K, Reid RD, Mackey JR, Friedenreich CM et al (2008) Predictors of supervised exercise adherence during breast cancer chemotherapy. Med Sci Sports Exerc 40:1180–1187CrossRefPubMedGoogle Scholar
  33. 33.
    Hsu H-T, Dodd MJ, Guo S-E, Lee KA, Hwang S-L, Lai Y-H (2011) Predictors of exercise frequency in breast cancer survivors in Taiwan. J Clin Nurs 20:1923–1935CrossRefPubMedGoogle Scholar
  34. 34.
    Ottenbacher AJ, Day RS, Taylor WC, Sharma SV, Sloane R, Snyder DC, Kraus WE, Demark-Wahnefried W (2011) Exercise among breast and prostate cancer survivors--what are their barriers? J Cancer Surviv Res Pract 5:413–419CrossRefGoogle Scholar
  35. 35.
    Gho SA, Munro BJ, Jones SC, Steele JR (2014) Perceived exercise barriers explain exercise participation in Australian women treated for breast cancer better than perceived exercise benefits. Phys Ther 94:1765–1774CrossRefPubMedGoogle Scholar
  36. 36.
    Courneya KS, Segal RJ, Gelmon K, Mackey JR, Friedenreich CM, Yasui Y, Reid RD, Proulx C, Trinh L, Dolan LB, Wooding E, Vallerand JR, McKenzie DC (2014) Predictors of adherence to different types and doses of supervised exercise during breast cancer chemotherapy. Int J Behav Nutr Phys Act 11:85CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Casla S, López-Tarruella S, Jerez Y, Marquez-Rodas I, Galvão DA, Newton RU, Cubedo R, Calvo I, Sampedro J, Barakat R, Martín M (2015) Supervised physical exercise improves VO2max, quality of life, and health in early stage breast cancer patients: a randomized controlled trial. Breast Cancer Res Treat 153:371–382CrossRefPubMedGoogle Scholar
  38. 38.
    Bluethmann SM, Vernon SW, Gabriel KP, Murphy CC, Bartholomew LK (2015) Taking the next step: a systematic review and meta-analysis of physical activity and behavior change interventions in recent post-treatment breast cancer survivors. Breast Cancer Res Treat 149:331–342CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Luoma M-L, Hakamies-Blomqvist L, Blomqvist C, Nikander R, Gustavsson-Lilius M, Saarto T (2014) Experiences of breast cancer survivors participating in a tailored exercise intervention –a qualitative study. Anticancer Res 34:1193–1199PubMedGoogle Scholar
  40. 40.
    Daley AJ, Crank H, Mutrie N, Saxton JM, Coleman R (2007) Determinants of adherence to exercise in women treated for breast cancer. Eur J Oncol Nurs 11:392–399CrossRefPubMedGoogle Scholar
  41. 41.
    Carayol M, Bernard P, Boiché J, Riou F, Mercier B, Cousson-Gélie F, Romain AJ, Delpierre C, Ninot G (2013) Psychological effect of exercise in women with breast cancer receiving adjuvant therapy: what is the optimal dose needed? Ann Oncol 24:291–300CrossRefPubMedGoogle Scholar
  42. 42.
    Rütten A, Abu-Omar K (2004) Prevalence of physical activity in the European Union. Soz Praventivmed 49:281–289PubMedGoogle Scholar
  43. 43.
    Gerovasili V, Agaku IT, Vardavas CI, Filippidis FT (2015) Levels of physical activity among adults 18-64 years old in 28 European countries. Prev Med 81:87–91CrossRefPubMedGoogle Scholar
  44. 44.
    Courneya KS, Rogers LQ, Campbell KL, Vallance JK, Friedenreich CM (2015) Top 10 research questions related to physical activity and cancer survivorship. Res Q Exerc Sport 86:107–116CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  • Aude-Marie Foucaut
    • 1
    • 2
  • Magali Morelle
    • 1
    • 3
  • Anne-Sophie Kempf-Lépine
    • 1
  • Cédric Baudinet
    • 1
  • Renaud Meyrand
    • 1
  • Séverine Guillemaut
    • 1
  • Séverine Metzger
    • 1
  • Valérie Bourne-Branchu
    • 1
  • Elodie Grinand
    • 1
  • Sylvie Chabaud
    • 1
  • David Pérol
    • 1
  • Julien Carretier
    • 1
  • Sophie E. Berthouze
    • 4
  • Eric Reynes
    • 5
  • Lionel Perrier
    • 1
    • 3
  • Paul Rebattu
    • 1
  • Pierre-Etienne Heudel
    • 1
  • Thomas Bachelot
    • 1
  • Patrick Bachmann
    • 1
  • Béatrice Fervers
    • 1
    • 6
  • Olivier Trédan
    • 1
  • Marina Touillaud
    • 1
    • 6
    • 7
    Email author
  1. 1.Léon Bérard Cancer CenterLyonFrance
  2. 2.Educations and Health Practices Laboratory (LEPS) (EA 3412), UFR SMBHParis 13 University, Sorbonne Paris CiteBobignyFrance
  3. 3.GATE Lyon Saint-Etienne, UMR-CNRS 5824University of LyonLyonFrance
  4. 4.Inter-university Laboratory of Human Movement Biology EA 7424University of Lyon - University Claude Bernard Lyon 1VilleurbanneFrance
  5. 5.Laboratory of Vulnerabilities and Innovation in Sport EA 7428University of Lyon - University Claude Bernard Lyon 1 FED 4272VilleurbanneFrance
  6. 6.Cancer Research Center of Lyon, UMR Inserm 1052 CNRS 5286 CLBLyonFrance
  7. 7.Department of Cancer and EnvironmentCentre Léon BérardLyonFrance

Personalised recommendations